I just wanted to edit to make it a bit more Lyme patient reader friendly:
First- a 'clickable' link:
/www.vdh.virginia.gov/epidemiology/DEE/Vectorborne/Governor%20Lyme%20Disease%20Task%20Force%20Report.pdf Now to continue on with American Lymie's post - part II:
II
General recommendation
Recommendation:
The task force should recommend that VDH receive funding to
enhance its tick-borne diseases program. Key elements of an
effective program include the following:
(i) human disease surveillance
(ii) tick surveillance and testing
(iii) general public and healthcare provider outreach and
education regarding the prevalence and prevention of
Lyme disease.
Any reference to education in these recommendations should
emphasize the need to provide an
open and balanced review of the
full body of literature.
Rationale:
Lyme disease is a significant health issue in Virginia, and VDH has
been working to track and prevent spread of this infection over the
last decade. As Lyme disease has become increasingly problematic
in Virginia during the last five years, surveillance and prevention
activities have become increasingly labor and resource intensive. A
strategic public health investment is necessary to enhance VDH’s
ability to prevent and control the spread of tick-borne diseases.
8
III
Specific Findings and Recommendations
In addition to these general observations, we make the following
specific findings and recommendations based on the testimony that
we received from our hearings:
A.
Diagnosis
1. As acknowledged by the CDC, Lyme disease and many related
tick-borne illnesses cannot be adequately diagnosed by
serology alone in many cases.
2. There is no serological test that can “rule out” Lyme disease.
3. Clinical diagnosis that may be supported by serology remains
the proper method for the diagnosis of Lyme and related
illnesses.
4. Clinical diagnosis is not limited to the observation of an EM
rash. A significant proportion of patients with Lyme disease
may never develop or observe such a rash. Moreover, the EM
rash can manifest in non-traditional patterns. The medical
community needs a more comprehensive set of visual
illustrations so that non-traditional patterns may be properly
recognized.
5. Many lay witnesses testified that members of Virginia’s
medical community inaccurately believed that serology alone
can “rule out” Lyme disease.
6. According to lay testimony, there are some members of the
Virginia medical community who have refused to consider a
diagnosis of Lyme and related illnesses on the ground that
“we do not have Lyme in Virginia” or in this “part of Virginia.”
Lyme disease is present in all parts of Virginia, endemic in
9
most parts of the state, and emerging throughout the
Commonwealth.
7. The testimony that came before the Task Force relayed the
highly questionable nature of the ELISA test for early localized
disease. We encourage the use of clinical judgment at all
stages due to the significant limitations of current serology.
8. We recommend that the VDH reporting form include the
disclaimer “The CDC case definition is designed for
surveillance purposes only. Clinical judgment should be
exercised in assessing patients for Lyme disease as meeting
the surveillance case definition is not required for the
diagnosis of Lyme disease.”
9. Since ticks often carry multiple pathogens and we received
testimony that many Virginians have multiple tick-borne
illnesses that may require comprehensive analysis and
treatment, the medical community should be educated on the
presence of co-infections.
10.Great caution should be taken whenever a blacklegged tick is
attached and especially if it is engorged. Patient reports
about
the length of time of attachment can be unreliable as
some patients may not have observed the exact moment of
attachment. Medical providers should be at their liberty to
treat Lyme disease prophylactically in such cases because of
the high risk of disease. (Note that single-dose prophylaxis
may lower the sensitivity of subsequent serology, as stated by
the CDC.) Moreover, it is clear that early treatment is very
important to prevent many serious complications of Lyme
disease.
11.The Task Force encourages increased financial support for
Internal Review Board-approved, peer-reviewed clinical
studies associated with Lyme disease diagnosis and
treatment. The Task Force encourages financial support for
Virginia’s college and university researchers who undertake
research on Lyme or tick-borne disease. This should include
10
all scientific realms. We commend Old Dominion University
for undertaking vital research in the Tidewater region.
(Rationale: Additional research that investigates the validity
and reliability of diagnostic and preventative tools and
provides guidance for appropriate treatment will support
quality of care and patient outcomes.)
12.The Task Force encourages institutions offering graduate-level
medical degrees to offer comprehensive instruction about
Lyme and other tick-borne diseases. Due to the rapidly
evolving nature of the scientific research and literature on
tick-borne disease, medical educators should use due
diligence to teach comprehensive and up-to-date information
in all aspects of tick-borne disease. (Rationale: Student
clinicians (medical, nurse practitioner and physician’s
assistant students) are the clinicians of the future and should
be aware of Lyme and other tick-borne diseases as medical
conditions in Virginia.)
13.VDH should continue to provide information to clinicians
practicing in the Commonwealth concerning the epidemiology
of Lyme disease in Virginia, a physician’s responsibility to
report Lyme disease, the information VDH requires to classify
a case, the purpose of the surveillance case definition, Lyme
disease prevention measures and tick identification. VDH
should also continue to provide information to clinicians
practicing in the Commonwealth about
other tick-borne
diseases in Virginia. (Rationale: This recommendation
articulates VDH’s current practice and speaks to its
commitment to continue these informational efforts in regard
to tick-borne disease, with a particular focus on Lyme disease
as it is the most commonly reported tick-borne disease and is
present in all parts of Virginia, endemic in most parts of the
state and emerging throughout the Commonwealth.) VDH
should emphasize that due to the rapidly evolving nature of
the scientific research and literature on Lyme and tick-borne
11
disease, medical professionals should use due diligence to
stay abreast of information in all aspects of tick-borne disease
to educate their ability to clinically assess patients.
B.